Bausch + LombvsThermo Fisher Scientific

BLCO and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Bausch + Lomb (BLCO) has a market value of $7.5B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, BLCO moved +27.0% and TMO +19.5%. Dividend yield: BLCO none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BLCO$7.5B

    TMO$260B

    TMO is 35 times BLCO

  • Revenue, 12 months

    BLCO$5.4B

    TMO$47.4B

    TMO is 8.7 times BLCO

  • Net income, 12 months

    BLCO-$111M

    TMO$7.1B

  • Operating margin

    BLCO7.1%

    TMO17.9%

    10.8 points apart

  • ROIC

    BLCO2.6%

    TMO8.2%

    5.6 points apart

  • P/E

    BLCO–

    TMO36.8

  • Dividend yield

    BLCO0.0%

    TMO0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BLCO+33.1%

TMO+58.8%

75100125150202420252026
Returns by period
PeriodBLCOWith dividendsTMOWith dividends
1 year since November 12, 2025+27.0%Price +27.0%+19.5%Price +19.1%
3 years since November 13, 2023+33.1%+10.0% a yearPrice +33.1%+58.8%+16.7% a yearPrice +57.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BLCOBausch + LombTMOThermo Fisher Scientific

Valuation

BLCOTMO
Valuation
Price$21.09$700.22
Market value$7.5B$260B
Enterprise value (EV)$12.0B$295B
P/E–36.8
P/E, 5-year median–32.7
P/B1.24.8
EV/EBIT31.334.9
Free cash flow yield3.4%2.9%

Results and growth

BLCOTMO
Results and growth
Revenue, 12 months$5.4B$47.4B
Net income, 12 months-$111M$7.1B
Free cash flow, 12 months$252M$7.6B
Earnings per share, 12 months-$0.32$18.96
Revenue growth, year on year6.5%3.9%
Revenue growth a year, past+8.4%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

BLCOTMO
Margins and returns on capital
Gross margin––
Operating margin7.1%17.9%
Net margin-2.1%14.9%
ROIC2.6%8.2%
ROE-1.7%13.4%

Balance sheet

BLCOTMO
Balance sheet
Cash$513M$6.1B
Total debt$5.0B$41.4B
Net debt / EBITDA5.63.7
Interest cover1.0×5.5×

Dividends and buybacks

BLCOTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BLCO or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Bausch + Lomb or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 34.8 times Bausch + Lomb ($7.5B), at today's prices.

How did BLCO and TMO stock do over the last 3 years?

Since November 13, 2023, BLCO's price moved +33.1% and TMO's +57.3%. With dividends: BLCO +33.1% (+10.0% a year), TMO +58.8% (+16.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, BLCO or TMO?

The dividend yield at today's price is none for Bausch + Lomb and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Bausch + Lomb or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -2.1% for Bausch + Lomb and 14.9% for Thermo Fisher Scientific, and the operating margin 7.1% and 17.9%. Revenue was $5.4B and $47.4B.

Which is the better investment, Bausch + Lomb or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.